UK pharma: 25 years of innovation and controversy
Whitefriars’ Ketan Patel discusses what investors need to consider when investing in the pharmaceutical sector
Whitefriars
-
-
COP29: Delivering on climate finance?
The summit, to be held in Baku in November, has attracted controversy on diversity, human rights and fossil fuels
-
Ex-EdenTree manager Ketan Patel sets up investment firm Whitefriars
Unveiling strategies investing across property, equities, bonds and alternatives